These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1763136)

  • 21. The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells.
    Hormes R; Homann M; Oelze I; Marschall P; Tabler M; Eckstein F; Sczakiel G
    Nucleic Acids Res; 1997 Feb; 25(4):769-75. PubMed ID: 9016627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The therapeutic potential of ribozymes.
    James HA; Gibson I
    Blood; 1998 Jan; 91(2):371-82. PubMed ID: 9427689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes.
    Ramezani A; Ma XZ; Ameli M; Arora A; Joshi S
    Front Biosci; 2006 Sep; 11():2940-8. PubMed ID: 16720366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic antisense and ribozymes.
    Rossi JJ
    Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1.
    Yu M; Ojwang J; Yamada O; Hampel A; Rapapport J; Looney D; Wong-Staal F
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6340-4. PubMed ID: 8327516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ribozymes: a modern tool in medicine.
    Khan AU; Lal SK
    J Biomed Sci; 2003; 10(5):457-67. PubMed ID: 12928586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozymes: recent advances in the development of RNA tools.
    Puerta-Fernández E; Romero-López C; Barroso-delJesus A; Berzal-Herranz A
    FEMS Microbiol Rev; 2003 Apr; 27(1):75-97. PubMed ID: 12697343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribozymes in gene therapy of HIV-1.
    Macpherson JL; Ely JA; Sun LQ; Symonds GP
    Front Biosci; 1999 Jun; 4():D497-505. PubMed ID: 10352136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic applications of group I intron-based trans-splicing ribozymes.
    Lee CH; Han SR; Lee SW
    Wiley Interdiscip Rev RNA; 2018 May; 9(3):e1466. PubMed ID: 29383855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of clinically relevant SOFA-HDV ribozymes targeting HIV RNA.
    Scarborough RJ; Lévesque MV; Perreault JP; Gatignol A
    Methods Mol Biol; 2014; 1103():31-43. PubMed ID: 24318884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribozymes: killing the messenger.
    Barinaga M
    Science; 1993 Dec; 262(5139):1512-4. PubMed ID: 8248799
    [No Abstract]   [Full Text] [Related]  

  • 36. Ribozymes as antiviral agents.
    Bartolomé J; Castillo I; Carreño V
    Minerva Med; 2004 Feb; 95(1):11-24. PubMed ID: 15041923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribozyme therapy for HIV infection.
    Rossi JJ
    Adv Drug Deliv Rev; 2000 Oct; 44(1):71-8. PubMed ID: 11035199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme.
    Ojwang JO; Hampel A; Looney DJ; Wong-Staal F; Rappaport J
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10802-6. PubMed ID: 1438280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
    Zhou C; Bahner IC; Larson GP; Zaia JA; Rossi JJ; Kohn EB
    Gene; 1994 Nov; 149(1):33-9. PubMed ID: 7958986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.
    Lainé S; Scarborough RJ; Lévesque D; Didierlaurent L; Soye KJ; Mougel M; Perreault JP; Gatignol A
    RNA Biol; 2011; 8(2):343-53. PubMed ID: 21422817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.